Cargando…
Cannabinoids in health and disease
Cannabis sativa L. preparations have been used in medicine for millenia. However, concern over the dangers of abuse led to the banning of the medicinal use of marijuana in most countries in the 1930s. Only recently, marijuana and individual natural and synthetic cannabinoid receptor agonists and ant...
Autores principales: | Kogan, Natalya M., Mechoulam, Raphael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202504/ https://www.ncbi.nlm.nih.gov/pubmed/18286801 |
Ejemplares similares
-
Cannabinoid Quinones—A Review and Novel Observations
por: Kogan, Natalya M., et al.
Publicado: (2021) -
Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats
por: Hen-Shoval, Danielle, et al.
Publicado: (2023) -
Effect of the synthetic cannabinoid HU-210 on quorum sensing and on the production of quorum sensing-mediated virulence factors by Vibrio harveyi
por: Soni, Divya, et al.
Publicado: (2015) -
CB2 Cannabinoid Receptor Targets Mitogenic Gi Protein–Cyclin D1 Axis in Osteoblasts
por: Ofek, Orr, et al.
Publicado: (2011) -
Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity
por: Kogan, Natalya M., et al.
Publicado: (2021)